Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Am J Kidney Dis. 2017 Nov 8;71(1):112–122. doi: 10.1053/j.ajkd.2017.08.015

Table 4.

Cumulative incidence of metabolic dysfunction in parous CARDIA women by race

Variable Black
n=331
White
n=489
p-value
Glucose intolerancea 0.08
 Yes 121 (36.6) 150 (30.7)
 No 210 (63.4) 339 (69.33)
Insulin resistanceb 0.6
 Yes 141 (42.6) 198 (40.5)
 No 190 (57.4) 291 (59.5)
HOMA-IR <0.001
 >4 114 (34.4) 63 (12.9)
 ≤4 217 (65.6) 426 (87.1)
HOMA-IR <0.001
 ≥ 2.73 192 (58.0) 145 (29.7)
 <2.73 139 (42.0) 344 (70.4)
Metabolic syndromec <0.001
 Yes 72 (21.8) 60 (12.3)
 No 259 (78.3) 429 (87.7)
Diabetes mellitus <0.001
 Yes 41 (12.4) 22 (4.5)
 No 290 (87.6) 467 (95.5)
Hypertension <0.001
 Yes 115 (34.7) 69 (14.1)
 No 216 (65.3) 420 (85.9)
GDM 0.8
 Yes 42 (12.7) 59 (12.1)
 No 289 (87.3) 430 (87.9)
CKD 0.001
 Yes 58 (17.5) 47 (9.6)
 No 273 (82.5) 442 (90.4)

Notes: Values presented are number (percentage). P-values obtained from Fisher’s exact test.

Abbreviations: CARDIA, Coronary Artery Risk Development in Young Adults; CKD, chronic kidney disease; GDM, gestational diabetes mellitus; HOMA-IR, Homeostatic Model Assessment of Insulin Resistance.